I really don’t know how important this would be.
I do know that Neuren filed an international patent application two years ago for new compositions and manufacturing methods which allow substantially larger quantities of trofinetide to be produced in a way that is more commercially beneficial.
The inventors listed on this patent are drawn from Neuren, Acadia and PeptiSyntha SA Belgium/ Corden Pharma Switzerland (Corden is the parent company of PeptiSyntha). So Corden is at least a conveniently located manufacturer for any European pharma.
Under the terms of the licence, Acadia was granted a non-exclusive licence to have trofinetide manufactured outside of North America.
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021026066&_cid=P11-L9FI68-39396-4
- Forums
- ASX - By Stock
- Share Price
I really don’t know how important this would be. I do know that...
-
- There are more pages in this discussion • 8,947 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.13 |
Change
-0.350(2.26%) |
Mkt cap ! $1.940B |
Open | High | Low | Value | Volume |
$15.20 | $15.33 | $15.02 | $3.167M | 208.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 646 | $15.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.16 | 160 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 868 | 15.130 |
8 | 813 | 15.120 |
9 | 674 | 15.110 |
4 | 446 | 15.100 |
5 | 551 | 15.090 |
Price($) | Vol. | No. |
---|---|---|
15.150 | 159 | 5 |
15.160 | 360 | 6 |
15.170 | 840 | 13 |
15.180 | 660 | 6 |
15.190 | 962 | 5 |
Last trade - 12.21pm 22/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |